Tratamento clínico da doença coronariana multiarterial estável. Menos é mais? / Medical therapy of stable multivessel coronary artery disease: less is more?
Int. j. cardiovasc. sci. (Impr.)
; 28(2): 160-162, mar.-abr. 2015.
Article
in En, Pt
| LILACS
| ID: lil-762458
Responsible library:
BR44.1
RESUMO
Apesar dos avanços de todas as formas de tratamento da doença arterial coronariana (DAC) estável, ainda háconsiderável controvérsia sobre as vantagens da revascularização miocárdica em comparação com o tratamento clínico (TC) contemporâneo. Na DAC multiarterial, os ensaios clínicos randomizados demonstraram que astécnicas de revascularização não reduziram a incidência de desfechos duros, como morte e infarto agudo domiocárdio não fatal. Desse modo, esses estudos sugerem que o TC, tratamento de menor custo, possa ser aplicadocomo terapia inicial nesses pacientes.
ABSTRACT
Despite the advances of all forms of treatment of stable coronary artery disease (CAD), there is still considerable controversy about the benefits of myocardial revascularization compared with medical therapy (CT). In multivessel CAD, randomized clinicaltrials have demonstrated that revascularization techniques did not reduce the incidence of hard outcomes, such as death and acute nonfatal myocardial infarction. Thus, these studies suggest that CT, lower cost treatment, may be applied as initial therapy for these patients.
Key words
Full text:
1
Index:
LILACS
Main subject:
Homeopathic Therapeutic Approaches
/
Coronary Disease
/
Myocardial Revascularization
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Humans
Language:
En
/
Pt
Journal:
Int. j. cardiovasc. sci. (Impr.)
Journal subject:
CARDIOLOGIA
Year:
2015
Type:
Article